captopril has been researched along with 3-nitrotyrosine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Deng, G; Jabbari, B; Ni, Z; Vaziri, ND; Yan, XX | 1 |
Alcaraz, A; Atucha, NM; Evangelista, S; García-Estañ, J; Navarro, EG; O'Valle, F; Ortiz, MC; Vargas, F | 1 |
Boggi, U; Bugliani, M; Del Guerra, S; Del Prato, S; Lupi, R; Marchetti, P; Mosca, F; Torri, S | 1 |
Chen, K; Gao, X; Hu, C; Jiang, Z; Liu, K | 1 |
4 other study(ies) available for captopril and 3-nitrotyrosine
Article | Year |
---|---|
Increased tyrosine nitration of the brain in chronic renal insufficiency: reversal by antioxidant therapy and angiotensin-converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Blotting, Western; Brain; Captopril; Kidney Failure, Chronic; Male; Pregnatrienes; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tyrosine | 2001 |
Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Diuretics; Drug Therapy, Combination; Enalapril; Hydrochlorothiazide; Hypertension; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tyrosine | 2006 |
The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Captopril; Enalaprilat; Female; Glucose; Humans; In Vitro Techniques; Insulin; Islets of Langerhans; Male; Middle Aged; Oxidative Stress; Peptidyl-Dipeptidase A; Proto-Oncogene Proteins c-akt; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tyrosine | 2006 |
Captopril alleviates oxidative damage in diabetic retinopathy.
Topics: Animals; Captopril; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Endothelial Cells; Glucose; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Retina; Retinal Vessels; Streptozocin; Tyrosine; Vascular Endothelial Growth Factor A | 2022 |